Phlebotonics for venous insufficiency
Martinez-Zapata MJ, Vernooij RW, Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, Capella D, Bonfill Cosp X
Published in Cochrane Database of Systematic Reviews
Key Findings
Phlebotonics including rutosides produced a small reduction in oedema and trophic disorders but no clear improvement in quality of life, with moderate-quality evidence.
Conclusions
Rutoside-type phlebotonics give small symptomatic benefit at best.
Limitations
Heterogeneous agents; many older, industry-funded trials.
Supplements Studied
Phlebotonics including rutosides produced a small reduction in oedema but no clear improvement in quality of life.
Phlebotonics are a class of drugs often used to treat CVI.
Outcomes Measured
Phlebotonics including rutosides reduced oedema slightly without clear quality of life gains.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.